TROFI: Minimal intra-stent flow area in STEMI patients post primary PCI with or without manual thrombus aspiration.

Professor Serruys presented the results of the TROFI trial that compares the minimal intra-stent flow area in STEMI patients post primary PCI with or without manual thrombus aspiration.

The minimal intra-stent flow area helps assess thrombus burden and is defined as: (stent area + incomplete stent apposition area) – (intralulminal defect area attached to the wall + intraluminal defect area free from the wall + tissue prolapse area). 

To measure the minimal flow area, researchers used a novel technology called ODFI (optical domain frequency imaging), an invasive tool that generates precise high resolution images (180 µ) capable of detecting and quantifying thrombi in stent lumen at implantation.

141 patients were randomized (1:1) to primary PCI with or without thrombectomy. After an optimal angiographic result, all patients were submitted to ODFI. The minimal flow area post stenting did not show significant variation (7,08±2,14 with thrombectomy vs. 6,51±1,99 without thrombectomy, P=0,12).

Conclusion: thrombectomy significantly reduced the impact of thrombus according to minimal flow area post-stenting. The use of this promising novel technology allows the assessment of intracoronary thrombi during PCI.

Serruys_x_430392-1
P. Serruys
2012-05-16

More articles by this author

DISCOVER FLOW: Correlation of conventional FFR vs non invasive FFR obtained with MSCT for successful stenting.

The DISCOVER FLOW trial has recently showed an excellent correlation between fractional flow reserve values (FFR) traditionally obtained with coronary CT angiography (CCTA) and...

CLI-OPCI: Optical coherence tomography (OCT)-guided stent implantation vs. conventional angiography guided angioplasty.

CLI-randomized study CLI-OPCI (n = 670, 1:1) evaluated the impact of stent implantation guided by angiography and optical coherence tomography (OCT), versus angioplasty guided...

DESolve I FIM: Evaluation of a FIM trial results of a bioabsorbable stent (15 patients).

 This trial is a prospective evaluation of DESolveTM bioabsorbable coronary stent implantation in a 15 patient cohort enrolled in New Zealand and Belgium. At...

SMART: Manual Thrombectomy vs. Rheolytic Aspiration in ST-segment Elevation Acute Myocardial Infarction.

Dr. David Antoniucci presented the immediate results of randomized trial SMART SMART (n=80, 1:1) comparing manual thrombectomy (MAT) vs. rheolytic aspiration (RT) in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long-Term Predictors of Valve Deterioration After TAVI

Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe aortic valve stenosis. Initially implemented in elderly...

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...